Browsing by Author Monreal M


Or, select a letter below to browse by last name
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 6 to 18 of 18 < previous 
PreviewTitleAuthor(s)Issue DateType
Fondaparinux in the initial and long-term treatment of venous thromboembolismPesavento R; Amitrano M; Trujillo-Santos J; Di Micco P; Mangiacapra S; López-Jiménez L; Piovella C; Prandoni P; Monreal M; RIETE Investigators.; Bosevski M ; Zdraveska M 2015Article
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registryAlatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators; Bosevski M ; Zdraveska M 2017Article
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators; Bosevski M ; Zdraveska M 2017Article
Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.Tafur AJ,; Caprini JA,; Cote L; Trujillo-Santos J; Del Toro J,; Garcia-Bragado F; Tolosa C,; Barillari G,; Visona A,; Monreal M; RIETE Investigators; Bosevski, M ; Zdraveska M 2017Article
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimensTrujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE RegistryBarillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
Systolic blood pressure and mortality in acute symptomatic pulmonary embolismQuezada A,; Jiménez D,; Bikdeli B,; Moores L,; Porres-Aguilar M,; Aramberri M,; Lima J,; Ballaz A,; Yusen RD, Monreal M; RIETE investigators.; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2020Article
Uterine bleeding during anticoagulation in women with venous thromboembolism.Moustafa F,; Fernández S,; Fernández-Capitán C,; Nieto JA,; Pedrajas JM,; Visoná A,; Valero B,; Marchena PJ,; Braester A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
Venous thromboembolism in centenarians: Findings from the RIETE registryLacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registryPortillo J; de la Rocha VI; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M; RIETE Investigations; Bosevski M ; Zdraveska M 2015Article
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous ThromboembolismChai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Marija Zdraveska ; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M; RIETE investigatorsApr-2018Article